Cargando…
Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus
Exosomes, nanometer-sized lipid-bilayer-enclosed extracellular vesicles (EVs), have attracted increasing attention due to their inherent ability to shuttle proteins, lipids and genes between cells and their natural affinity to target cells. Their intrinsic features such as stability, biocompatibilit...
Autores principales: | Ortega, Ana, Martinez-Arroyo, Olga, Forner, Maria J., Cortes, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821934/ https://www.ncbi.nlm.nih.gov/pubmed/33374908 http://dx.doi.org/10.3390/pharmaceutics13010003 |
Ejemplares similares
-
Increased Urinary Exosomal MicroRNAs in Patients with Systemic Lupus Erythematosus
por: Perez-Hernandez, Javier, et al.
Publicado: (2015) -
Plasma Exosomal Non-Coding RNA Profile Associated with Renal Damage Reveals Potential Therapeutic Targets in Lupus Nephritis
por: Flores-Chova, Ana, et al.
Publicado: (2023) -
Advanced Nanovehicles-Enabled Delivery Systems of Epigallocatechin Gallate for Cancer Therapy
por: Li, Kai, et al.
Publicado: (2020) -
Progress of exosome research in systemic lupus erythematosus
por: Shen, Jie, et al.
Publicado: (2022) -
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
por: Li, Nuannuan, et al.
Publicado: (2021)